FDA Approves Genzyme’s Mozobil For Bone Marrow Transplant Prep
This article was originally published in The Pink Sheet Daily
Executive Summary
Firm gains FDA approval for Mozobil, though it likely will encounter commercialization road bumps.
You may also be interested in...
Genzyme Strengthens Oncology And MS Portfolios With Bayer Deal
The complicated deal bolsters Genzyme’s developing oncology franchise and provides a potential MS blockbuster without requiring an up-front payment.
Genzyme Strengthens Oncology And MS Portfolios With Bayer Deal
The complicated deal bolsters Genzyme’s developing oncology franchise and provides a potential MS blockbuster without requiring an up-front payment.
ASH Preview: Researchers Chase Winning Combination In Frontline Myeloma
At this year's American Society of Hematology meeting, scientists will present data suggesting a cocktail of Revlimid, Velcade and dexamethasone could emerge as the backbone of frontline therapy for multiple myeloma